QuantCapitol. Congressional Trading Intelligence

Updated 2026-11-05 21:54 UTC · Public disclosure record

CXTICKER

Cemex Sab De Cv

INSUFFICIENT DATA stock

Congress has disclosed 3 buys and 1 sell of CX (Cemex Sab De Cv) in official financial disclosures, each linked to its original filing. A transparency record — not investment advice.

Activity Congressional Activity

3
Buy
1
Sell
+2
Net
2
Active politicians
Price & congressional trades
Buy Sell

4 trades Recent Congressional Trades

Two things to watch per trade: the disclosure lag (how many days passed before the trade was made public) and the price move in that window (how the stock moved during those non-public days). A sell followed by a price drop, or a buy followed by a rise, means well-timed trading — visible here in the open. Note: the Score measures how notable a trade is, not whether it made money — the price move is shown for context and isn't part of it.

PoliticianChamberTypeOwnerDateDisclosure lagPrice move
in that
window
AmountScoreSource
Sheri Biggs House SELL Spouse · W.S.B Trust > UBS Financial Services Inc 35 2025-03-18 146 days +43.0% $1K–$15K
<0.1% of NW
62.7 ↗ filing
Gary Palmer House BUY Self 2018-08-06 0 days — $1K–$15K
0.3% of NW
22.3 ↗ filing
Gary Palmer House BUY Joint 2018-07-12 0 days — $1K–$15K
0.3% of NW
40.4 ↗ filing
Gary Palmer House BUY Spouse 2018-05-24 0 days — $1K–$15K
0.3% of NW
75.9 ↗ filing

Corporate insiders · SEC Form 4 Insider Activity

What the company's own officers and directors did in CX — open-market purchases and sales from SEC Form 4 filings (option exercises, grants and tax withholding are excluded). This is context for the congressional activity above, never a buy/sell signal, and the two datasets are kept separate on purpose. Does convergence mean anything? →

0
Congress trades with insider convergence
0
…with insider divergence
4
Insider open-market trades

Of the congressional trades in CX, 0 coincided with corporate insiders moving the same way within 60 days, and 0 with insiders moving the opposite way. This is co-occurrence only — whether it carries any edge is tested honestly on the convergence page.

DateInsiderRoleTypeSizeSource
2026-09-30 Doehner Cobian Mauricio Other SELL $8.9M ↗ EDGAR
2026-09-25 Zambrano Lozano Rogelio Director BUY $6.9M ↗ EDGAR
2026-08-19 Elizondo de la Garza Oscar Balmore Other SELL $2.3M ↗ EDGAR
2026-04-28 Gonzalez Herrera Jesus Vicente C-suite SELL $426K ↗ EDGAR

Combined timeline — Congress & insiders

Both sets of trades on one timeline, newest first, so you can see when they lined up. Congress vs ◆ insider.

DateWhoTypeSize
◆ insider 2026-09-30 Doehner Cobian Mauricio Other SELL $8.9M
◆ insider 2026-09-25 Zambrano Lozano Rogelio Director BUY $6.9M
◆ insider 2026-08-19 Elizondo de la Garza Oscar Balmore Other SELL $2.3M
◆ insider 2026-04-28 Gonzalez Herrera Jesus Vicente C-suite SELL $426K
Congress 2025-03-18 Sheri Biggs SELL $1K–$15K
Congress 2018-08-06 Gary Palmer BUY $1K–$15K
Congress 2018-07-12 Gary Palmer BUY $1K–$15K
Congress 2018-05-24 Gary Palmer BUY $1K–$15K

FAQ Common questions

How much has Congress traded CX?

3 disclosed buys and 1 sells of CX (Cemex Sab De Cv) appear in official congressional financial disclosures.

Is it legal for members of Congress to trade CX?

Members of Congress may trade stocks but must disclose it under the STOCK Act. QuantCapitol tracks those public disclosures for transparency — nothing here is an accusation of wrongdoing or investment advice.

Where does this data come from?

Official US House Clerk and Senate electronic financial disclosures. Every trade links back to its original filing so you can verify it yourself.

About this data. Sourced from official House Clerk and Senate eFD financial disclosures (Senate via a maintained community mirror — see project documentation). Transaction amounts are reported as ranges, not exact figures. Interest scores, consensus labels, and backtested performance are proprietary analytical calculations based on public data and are not investment advice. Backtested performance is a hypothetical simulation, not actual portfolio performance.